BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27756752)

  • 1. TSC2 Deficiency Unmasks a Novel Necrosis Pathway That Is Suppressed by the RIP1/RIP3/MLKL Signaling Cascade.
    Filipczak PT; Thomas C; Chen W; Salzman A; McDonald JD; Lin Y; Belinsky SA
    Cancer Res; 2016 Dec; 76(24):7130-7139. PubMed ID: 27756752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
    Zhang L; Feng Q; Wang T
    Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitate induces RIP1/RIP3-dependent necrosis via MLKL-mediated pore formation in the plasma membrane of RAW 264.7 cells.
    Kim SK; Yun M; Seo G; Lee JY; Lee SB
    Biochem Biophys Res Commun; 2017 Jan; 482(2):359-365. PubMed ID: 27856241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.
    Marunouchi T; Nishiumi C; Iinuma S; Yano E; Tanonaka K
    Eur J Pharmacol; 2021 May; 898():173987. PubMed ID: 33640405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation.
    Hu S; Chang X; Zhu H; Wang D; Chen G
    Cytokine; 2020 May; 129():155046. PubMed ID: 32114297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway.
    Zhou J; Li G; Han G; Feng S; Liu Y; Chen J; Liu C; Zhao L; Jin F
    Invest New Drugs; 2020 Feb; 38(1):50-59. PubMed ID: 30924024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
    Liu M; Li H; Yang R; Ji D; Xia X
    J Neuroinflammation; 2022 Oct; 19(1):262. PubMed ID: 36289519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.
    Sun W; Wu X; Gao H; Yu J; Zhao W; Lu JJ; Wang J; Du G; Chen X
    Free Radic Biol Med; 2017 Jul; 108():433-444. PubMed ID: 28414098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
    Zhang T; Zhang Y; Cui M; Jin L; Wang Y; Lv F; Liu Y; Zheng W; Shang H; Zhang J; Zhang M; Wu H; Guo J; Zhang X; Hu X; Cao CM; Xiao RP
    Nat Med; 2016 Feb; 22(2):175-82. PubMed ID: 26726877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
    Mi R; Ma J; Zhang D; Li L; Zhang H
    J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.
    Kaiser WJ; Sridharan H; Huang C; Mandal P; Upton JW; Gough PJ; Sehon CA; Marquis RW; Bertin J; Mocarski ES
    J Biol Chem; 2013 Oct; 288(43):31268-79. PubMed ID: 24019532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury.
    Hu Y; Pan H; Peng J; He J; Tang M; Yan S; Rong J; Li J; Zheng Z; Wang H; Liu Y; Zhong X
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):430-437. PubMed ID: 33686403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.
    Chen YF; Zhao ZQ; Wu ZM; Zou ZY; Luo XJ; Li J; Xie C; Liang Y
    Int J Clin Exp Pathol; 2014; 7(12):8411-20. PubMed ID: 25674205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Necroptosis in Ligand-Mediated and Hypoxia-Induced Injury of Hepatocytes Using a Novel Optic Probe-Detecting Receptor-Interacting Protein (RIP)1/RIP3 Binding.
    Haga S; Kanno A; Ozawa T; Morita N; Asano M; Ozaki M
    Oncol Res; 2018 Apr; 26(3):503-513. PubMed ID: 28770700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [RIP1/RIP3-MLKL signaling pathway correlates with occurrence, progression and prognosis of chronic heart failure].
    Chen Y; Li X; Lai W; Zhu F; Tan X; Xian W; Kang P; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1534-1539. PubMed ID: 34755669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panax notoginseng Saponins Protect Brain Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Resupply-Induced Necroptosis via Suppression of RIP1-RIP3-MLKL Signaling Pathway.
    Hu Y; Lei H; Zhang S; Ma J; Kang S; Wan L; Li F; Zhang F; Sun T; Zhang C; Li W
    Neurochem Res; 2022 Nov; 47(11):3261-3271. PubMed ID: 35904697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activation of CB2 receptor protects against ethanol-induced myocardial injury related to RIP1/RIP3/MLKL-mediated necroptosis.
    Liu X; Zhang D; Dong X; Zhu R; Ye Y; Li L; Jiang Y
    Mol Cell Biochem; 2020 Nov; 474(1-2):1-14. PubMed ID: 32681290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
    Ma L; Chen Z; Erdjument-Bromage H; Tempst P; Pandolfi PP
    Cell; 2005 Apr; 121(2):179-93. PubMed ID: 15851026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Park JH; Jung KH; Kim SJ; Yoon YC; Yan HH; Fang Z; Lee JE; Lim JH; Mah S; Hong S; Kim YS; Hong SS
    Cancer Lett; 2019 Mar; 444():94-104. PubMed ID: 30583075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.